Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

In January, New Jersey removed the bald eagle—now officially the U.S. national bird—from its list of endangered species.